BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$258M
This Quarter Return
-6.62%
1 Year Return
+11.26%
3 Year Return
+79.24%
5 Year Return
+149.9%
10 Year Return
+528.55%
AUM
$233M
AUM Growth
+$233M
(-11%)
Cap. Flow
-$8.71M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
70.67%
Holding
62
New
1
Increased
3
Reduced
28
Closed
1
Top Buys
| 1 |
Rio Tinto
RIO
|
$204K |
| 2 |
NVIDIA
NVDA
|
$46.1K |
| 3 |
Pacific Biosciences
PACB
|
$33.6K |
| 4 |
Symbotic
SYM
|
$23.2K |
Top Sells
| 1 |
Idexx Laboratories
IDXX
|
$3.24M |
| 2 |
Adobe
ADBE
|
$1.73M |
| 3 |
Bristol-Myers Squibb
BMY
|
$768K |
| 4 |
Microsoft
MSFT
|
$707K |
| 5 |
Paychex
PAYX
|
$484K |
Sector Composition
| 1 | Technology | 44.71% |
| 2 | Healthcare | 20.65% |
| 3 | Communication Services | 15.32% |
| 4 | Industrials | 6.31% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nutrien
NTR
$28B
| $1.68M | 0.72% | 33,832 -100 | -0.3% | -$4.97K |
|
27
Boston Scientific
BSX
$156B
| $1.6M | 0.69% | 15,898 -50 | -0.3% | -$5.04K |
|
28
L3Harris
LHX
$51.9B
| $1.45M | 0.62% | 6,940 | – | – |
|
|
29
Pacific Biosciences
PACB
$393M
| $1.15M | 0.49% | 972,255 +28,500 | +3% | +$33.6K |
|
30
AT&T
T
$209B
| $1.08M | 0.46% | 38,169 | – | – |
|
31
Public Service Enterprise Group
PEG
$41.1B
| $911K | 0.39% | 11,072 -325 | -3% | -$26.7K |
|
32
Palantir
PLTR
$372B
| $852K | 0.37% | 10,100 | – | – |
|
33
Lowe's Companies
LOW
$145B
| $816K | 0.35% | 3,500 | – | – |
|
34
SPDR Gold Trust
GLD
$107B
| $684K | 0.29% | 2,375 | – | – |
|
35
CenterPoint Energy
CNP
$24.6B
| $607K | 0.26% | 16,766 | – | – |
|
36
PepsiCo
PEP
$204B
| $542K | 0.23% | 3,615 | – | – |
|
37
Pfizer
PFE
$141B
| $508K | 0.22% | 20,055 -850 | -4% | -$21.5K |
|
38
Home Depot
HD
$405B
| $491K | 0.21% | 1,340 | – | – |
|
39
T Rowe Price
TROW
$23.6B
| $466K | 0.2% | 5,067 -4,000 | -44% | -$367K |
|
40
Merck
MRK
$210B
| $425K | 0.18% | 4,737 | – | – |
|
41
EOG Resources
EOG
$68.2B
| $417K | 0.18% | 3,251 | – | – |
|
42
Exxon Mobil
XOM
$487B
| $402K | 0.17% | 3,377 | – | – |
|
43
Gilead Sciences
GILD
$140B
| $390K | 0.17% | 3,480 -100 | -3% | -$11.2K |
|
44
JPMorgan Chase
JPM
$829B
| $380K | 0.16% | 1,550 | – | – |
|
45
Southern Company
SO
$102B
| $361K | 0.16% | 3,931 | – | – |
|
46
Microchip Technology
MCHP
$35.1B
| $361K | 0.15% | 7,455 -240 | -3% | -$11.6K |
|
47
Schlumberger
SLB
$55B
| $353K | 0.15% | 8,450 | – | – |
|
48
Intuit
INTU
$186B
| $348K | 0.15% | 566 | – | – |
|
49
Stryker
SYK
$150B
| $329K | 0.14% | 884 | – | – |
|
50
Procter & Gamble
PG
$368B
| $322K | 0.14% | 1,891 | – | – |
|